National Institute for Health Research
Europe, Orkney, United Kingdom, Whitehall'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
National Institute for Health Research is a biotechnology company that provides facilities and technology for researchers to thrive.
Investor Profile
National Institute for Health Research has made 20 investments, with 3 in the past 12 months and 70% as lead.
Stage Focus
- Grant (90%)
- Pre Seed (5%)
- Series Unknown (5%)
Country Focus
- United Kingdom (80%)
- Canada (10%)
- United States (10%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Medical Device
- Therapeutics
- Life Science
- Pharmaceutical
- Health Diagnostics
- Information Services
- Non Profit
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
